APAP 325 mg / Caffeine 32.5 mg / Guaifenesin 200 mg / Phenylephrine Hydrochloride 10 mg Oral Tablet
RxNorm 1144206
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1144206 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: APAP 325 mg / Caffeine 32.5 mg / Guaifenesin 200 mg / Phenylephrine Hydrochloride 10 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Acetaminophen 325 mg / caffeine 32.5 mg / guaifenesin 200 mg / phenylephrine hydrochloride 10 mg Oral Tablet
(Atom ID: 12331852)
TMSY
Tall Man Lettering Synonym (TMSY):
Acetaminophen 325 mg / caffeine 32.5 mg / guaiFENesin 200 mg / phenylephrine hydrochloride 10 mg Oral Tablet
(Atom ID: 12384021)
SY
Synonym (SY):
APAP 325 mg / Caffeine 32.5 mg / Guaifenesin 200 mg / Phenylephrine Hydrochloride 10 mg Oral Tablet
(Atom ID: 3800840)
TMSY